Mutagenicity of vaginal spermicides containing nonoxynol-9 in a bacterial assay

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 10, 2004, Pages 817-824

  Lambert, Peter C ^a   Peters, Claudine ^a   Centurión, Santiago A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Mutagenicity tests; Nonoxynol; Spermicidal agents

Indexed keywords

LIVER EXTRACT; MUTAGENIC AGENT; NON PRESCRIPTION DRUG; NONOXINOL 9; SPERMICIDAL AGENT;

AMES TEST; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GAMETE; GEL; MUCOSA; MUTAGENICITY; MUTATION; NONHUMAN; PRIORITY JOURNAL; ZYGOTE;

CULTURE MEDIA; EVALUATION STUDIES; FEMALE; GELS; HUMANS; MUTAGENICITY TESTS; NONOXYNOL; SALMONELLA TYPHIMURIUM; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SPERMATOCIDAL AGENTS; VAGINOSIS, BACTERIAL;

EID: 7244253298     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hartman PE, Hartman Z, Stahl RC, et al: Classification and mapping of spontaneous and induced mutations in the histidine operon of Salmonella. Adv Genet 1971;16:1-34
2. Ames BN, Gurney EG, Miller JA: Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorence and other aromatic amine carcinogens. Proc Natl Acad Sci USA 1972;69:3128-3132
3. Ames BN, Lee FD, Durston WE: An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci USA 1973;70:782-786
4. Alberts B, Bray D, Lewis J: Molecular Biology of the Cell. Third edition. New York, Garland Publishing, 1994
5. Mortelmans K, Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutat Res 2000;455:29-60
6. Wilkinson RG, Gemski P, Stocker BAD: Non-smooth mutants of Salmonella typhimurium: Differentiation by phage sensitivity and genetic mapping. J Gen Microbiol 1972;70:527-554
7. Ames BN, Whitfield HJ Jr: Frameshift mutagenesis in Salmonella. Cold Spring Harbor Symp Quant Biol 1966;23:221-225
8. US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Institutes of Health: Biosafety in Microbiological and Biomedical Laboratories. Fourth edition, Washington DC, US Government Printing Office, 1999
9. Zeiger E, Haseman JK, Shelby MD: Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals. Environ Mol Mutagen (Suppl) 1990;16:1-14
10. Butter HS, Swierenga SHH, Matula TI: Evaluation of the cyotoxicity and genotoxicity of the germicides nonoxynol-9 and octoxynol-9. Toxicol Lett 1986;31:65-73
11. Meyer O, Andersen PH, Hansen EV: Teratogenicity and in vitro mutagenicity studies on nonoxynol-9 and -30. Pharm Toxicol 1988;62:236-238
12. United States Food and Drug Administration: Data do not support association between spermicides, birth defects. FDA Drug Bull 1986;16:21
13. Einarson TR, Koren G, Matrice D: Maternal spermicide use and adverse reproductive outcome: A meta-analysis. Am J Obstet Gynecol 1990;162:655-660
14. Smith ESO, Dafoe CS, Miller JR: An epidemiological study of congenital reduction deformities of the limbs. Br J Prevent Social Med 1977;31:39-41
15. Jick H, Walker AM, Rothman KJ: Vaginal spermicides and congenital disorders. JAMA 1981;245:1329-1332
16. Huggins G, Vessey M, Flavel RK: Vaginal spermicides and outcome of pregnancy: Findings in a large cohort study. Contraception 1982;25:29-30
17. Mills JL, Harley EE, Reed GF: Are spermicides teratogenic? JAMA 1982;248:2148-2151
18. Polednak AP, Janerich DT, Glebatis DM: Birth weight and birth defects in relation to maternal spermicide use. Teratology 1982;26:27-38
19. Rothman KJ: Spermicide use and Down's syndrome. Am J Public Health 1982;72:399-401
20. Shapiro S, Slone D, Heinonen OP, et al: Birth defects and vaginal spermicides. JAMA 1982;247:2381-2384
21. Bracken MB, Vita K. Frequency of non-hormonal contraception around contraception and association with congenital malformations in offspring. Am J Epidemiol 1983;117:281-291
22. Cordero JF, Layde PM: Vaginal spermicides, chromosomal abnormalities and limb reduction defects. Fam Plann Perspect 1983;15:16-18
23. Linn S, Schoenbaum SC, Monson RR: Lack of association between contraceptive usage and congenital malformations in offspring. Am J Obstet Gynecol 1983;147:923-928
24. Mills JK, Reed GF, Nugent RP: Are there adverse effects of periconceptional spermicide use? Fertil Steril 1985;43:442-446
25. Louik C, Mitchell AA, Werler MM: Maternal exposure to spermicides in relation to certain birth defects. N Engl J Med 1987;317:474-478
26. Warburton D, Neugut RH, Lustenberger A: Lack of association between spermicide use and trisomy. N Engl J Med 1987;317:478-482
27. Strobino B, Kline J, Warburton D: Spermicide use and pregnancy outcome. Am J Public Health 1988;78:260-263
28. Van Peenen PFD, Nelson NA: Spermicides and Down's syndrome. Am J Public Health 1982;72:1047-1048
29. Bracken MB: Vaginal spermicides and congenital disorders: Study reassessed, not retracted (lett). JAMA 1987;257:2919
30. Watkins RN: Vaginal spermicides and congenital disorders: The validity of a study (lett) JAMA 1986;256:3095
31. Holmes LB: Vaginal spermicides and congenital disorders: The validity of a study (lett). JAMA 1986;256:3096
32. Oakley GP: Spermicides and birth defects (edit). JAMA 1982;247:2405
33. Bracken MB: Spermicidal contraceptives and poor reproductive outcomes: The epidemiologic evidence against an association. Am J Obstet Gynecol 1985;151:552-556
34. Simpson JL, Phillips OP: Spermicides, hormonal contraception and congenital malformations. Adv Contraception 1990;6:141-167
35. Committee on Gynecologic Practice, American College of Obstetrics and Gynecology: Contraceptives and congenital anomalies. Int J Gynecol Obstet 1993;42:316-317
36. Alter BP: Fanconi's anemia and its variability. Br J Haematol 1993;85:9-14